← Back to home

Gene-Level AI Health Management — A Few Hundred Yuan of Genetic Data + AI = Personal Physician Parity

Long-Form Video · EP0004 May 10, 2026 12:08
What this episode covers

"Nutrition management and disease prevention precise down to the gene" used to mean paying millions of dollars for a medical team. I spent a stretch running a health management program for corporate executives, so I know exactly how expensive this used to be — this episode drives it down to a few hundred yuan.

  • Genome sequencing is the single most worthwhile test I've ever had: it never changes, and the science keeps improving, so one test serves you for life
  • Don't take the extended data (it's inferred, not accurate) — just download the raw core data
  • Dumping 1.2 million rows on the AI isn't the job — you first build a gene-locus "allowlist" out of PubMed
  • AI doesn't stop at reading your genome: it scrapes checkup packages and cross-references your medical history to build a custom screening plan
  • Being able to drink ≠ your liver tolerating it — how fast your genes metabolize alcohol and how much damage your liver can take are two different things

"This is the healthcare parity AI brings."

“Nutrition management and disease prevention precise down to the gene” — modern medicine can already do this. Ordinary people just can’t afford it.

I used to run the personal physician business at Xingshulin, building bespoke physician services for entrepreneurs and corporate executives. I know exactly how expensive that used to be. Today is about driving the price down to where ordinary people can afford it.

1. Genome sequencing is the most worthwhile test I’ve ever had

Over a decade ago I had full genome sequencing done at WeGene. A 20-plus-megabyte document, close to 1.2 million rows — one locus per row, A/G/T/C, the body’s source code.

Why is it the most worthwhile? Because your genome never changes, but the science keeps advancing. Every other test gives you one result today and a different one tomorrow; you have to keep repeating it. Sequence once and it serves you for life, letting you understand your own body better as the science improves.

A few hundred yuan gets it done. Those several-thousand-to-ten-thousand-yuan “full interpretation” packages on the market aren’t necessary — the extra money is buying you the “interpretation” part, and interpretation is exactly what AI can now do instead.

On the WeGene site: My Genome → Raw Data → download the “core data” (not the extended data, which is 10-million-plus inferred rows and isn’t accurate). With other providers, just ask support for the “raw data.”

2. Don’t just hand it to the AI — you need an allowlist

Dumping 1.2 million rows straight into an AI is useless — the vast majority of those loci have nothing to do with your health.

What you do instead: build an allowlist of gene sequences confirmed by clinical trials, drawn from top-tier global medical databases like PubMed — roughly 10,000-plus entries. The expression of these loci already has strong established correlation with human disease and pharmacology. These are credible, not fortune-telling.

Apply for a PubMed API key at NCBI (National Library of Medicine) and the AI can pull papers several hundred times per minute for source retrieval and evidence-building.

3. What the AI did for me goes beyond reading my genome

Before my checkup late last year, I had this AI system run through everything first. Here’s what it did.

I went to the Meinian Onehealth site and had the AI scrape the prices and test items for every men’s package, then combined that with my genetic data and my medical history to build me a tailored screening plan.

  • A custom screening plan: core mandatory tests plus high-risk specialty panels, nothing missed. Last year I was diagnosed with cubital tunnel syndrome (nerve compression from long hours at a computer), so this year it had me redo EMG and nerve conduction velocity; hypercoagulability, metabolic panels, imaging — all covered
  • An execution plan: it recommended Meinian’s “Deluxe Premium Men’s Checkup Package” at ¥2,749 to cover most items, listed the remaining few to do at a Class-A tertiary hospital, and laid out the appointment process
  • Pharmacogenomics: which drugs I metabolize slowly, which ones won’t work well on me — precise input for my attending physician’s prescribing
  • Exercise guidance: I “warm up fast but recover slowly” — my heart rate stays elevated after stopping high-intensity exercise, which badly disrupts the first half of my night’s sleep. So I moved football from 10 p.m. to 6 or 7 in the afternoon
  • Supplements: dosages calibrated to my weight and my age in my forties. For example, I have a B12 transport issue, which is part of what caused last year’s cubital tunnel syndrome, so I now take mecobalamin daily

Every single conclusion links back to the original paper. This isn’t the AI guessing. And because most of the studies use European and American samples, the system also calibrates against Chinese population databases.

4. A few specific risk loci (from my own report)

The first thing that jumped out of the report was non-alcoholic fatty liver disease and liver fibrosis — it runs in my family, my father is a leading cardiothoracic surgeon in China, and he drinks pretty hard. I like to joke that I’m a “Shandong-Liaoning hybrid,” so I can hold my liquor.

But the report was blunt: my risk of cirrhosis and liver cancer from alcohol intake is 2.44x.

Being able to drink ≠ your liver tolerating it. “Able to drink” is the speed at which you metabolize alcohol; “tolerance” is how much damage your liver can absorb. The two are not proportional. Metabolizing fast doesn’t mean your liver escapes harm. Without a genetic report telling you this, you would never know.

The second was systemic sclerosis / Raynaud’s phenomenon. I love football, and when I play in indoor domes in the winter my fingers and ears go numb and cold unusually easily. After seeing the report, winter football means gloves and ear covers, no exceptions.

The third relates to thrombosis risk. I ran a guesthouse in Yunnan for four years, and years at high altitude left my red blood cell and platelet counts a few percentage points above normal — add family history, and high blood lipids become something I have to watch closely. I’ve also stopped the creatine I used to take before exercise, and I top up potassium and magnesium in the afternoon.

5. The healthcare parity AI brings

Producing a health management report this precise used to require spending millions of dollars on a medical team (think Project Blueprint and the like).

Now: a few hundred yuan for one genome test + AI analysis + PubMed grounding + Chinese population database correction = a report of equivalent depth.

This is the healthcare parity AI brings — work that used to take a medical team costing millions of dollars, now driven down to a few hundred yuan.

We’ve been running this for a year with a group of executives and founders, using a “physician + health coach” model. The genome doesn’t change, so the report keeps updating as medicine advances — you only have to do the test once.

Work that used to take a medical team costing millions of dollars — AI drives it down to a few hundred yuan.